NASDAQ:XRAY - Dentsply Sirona Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$46.57 +0.36 (+0.78 %)
(As of 05/27/2018 09:55 AM ET)
Previous Close$46.57
Today's Range$46.18 - $46.86
52-Week Range$44.21 - $68.98
Volume2.02 million shs
Average Volume2.91 million shs
Market Capitalization$10.59 billion
P/E Ratio17.77
Dividend Yield0.75%
Beta1.26

About Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona logoDENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The company also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials. In addition, it provides dental technology products, including dental implants and related scanning equipment, treatment software, and orthodontic appliances for dental practitioners and specialist, and dental laboratories; and dental equipment, such as treatment centers, imaging equipment, and computer aided design and machining systems for dental practitioners and laboratories. Further, the company offers healthcare consumable products, such as urology catheters, various surgical products, medical drills, and other non-medical products. It markets and sells dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and urology products directly to patients, as well as through distributors to urologists, urology nurses, and general practitioners. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in York, Pennsylvania.

Receive XRAY News and Ratings via Email

Sign-up to receive the latest news and ratings for XRAY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Dental equipment & supplies
Sub-IndustryHealth Care Supplies
SectorMedical
SymbolNASDAQ:XRAY
CUSIP24903010
Phone717-845-7511

Debt

Debt-to-Equity Ratio0.25
Current Ratio2.23
Quick Ratio1.46

Price-To-Earnings

Trailing P/E Ratio17.77
Forward P/E Ratio17.98
P/E Growth2.34

Sales & Book Value

Annual Sales$3.99 billion
Price / Sales2.65
Cash Flow$11.2488 per share
Price / Cash4.14
Book Value$29.48 per share
Price / Book1.58

Profitability

EPS (Most Recent Fiscal Year)$2.66
Net Income$-1,550,000,000.00
Net Margins-38.32%
Return on Equity8.63%
Return on Assets5.67%

Miscellaneous

Employees16,100
Outstanding Shares227,440,000

Dentsply Sirona (NASDAQ:XRAY) Frequently Asked Questions

What is Dentsply Sirona's stock symbol?

Dentsply Sirona trades on the NASDAQ under the ticker symbol "XRAY."

How often does Dentsply Sirona pay dividends? What is the dividend yield for Dentsply Sirona?

Dentsply Sirona announced a quarterly dividend on Wednesday, April 25th. Investors of record on Friday, June 29th will be paid a dividend of $0.0875 per share on Friday, July 13th. This represents a $0.35 dividend on an annualized basis and a yield of 0.75%. The ex-dividend date is Thursday, June 28th. View Dentsply Sirona's Dividend History.

How were Dentsply Sirona's earnings last quarter?

Dentsply Sirona (NASDAQ:XRAY) released its quarterly earnings results on Sunday, May, 6th. The medical instruments supplier reported $0.45 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.42 by $0.03. The medical instruments supplier earned $956.10 million during the quarter, compared to analysts' expectations of $942.20 million. Dentsply Sirona had a negative net margin of 38.32% and a positive return on equity of 8.63%. The company's revenue for the quarter was up 6.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.49 earnings per share. View Dentsply Sirona's Earnings History.

When is Dentsply Sirona's next earnings date?

Dentsply Sirona is scheduled to release their next quarterly earnings announcement on Wednesday, August, 8th 2018. View Earnings Estimates for Dentsply Sirona.

What guidance has Dentsply Sirona issued on next quarter's earnings?

Dentsply Sirona updated its FY18 earnings guidance on Monday, May, 7th. The company provided EPS guidance of $2.55-2.65 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.70.

What price target have analysts set for XRAY?

13 brokers have issued 12-month price objectives for Dentsply Sirona's shares. Their predictions range from $52.00 to $75.00. On average, they expect Dentsply Sirona's stock price to reach $62.6667 in the next twelve months. View Analyst Ratings for Dentsply Sirona.

What are Wall Street analysts saying about Dentsply Sirona stock?

Here are some recent quotes from research analysts about Dentsply Sirona stock:
  • 1. According to Zacks Investment Research, "In the past year, DENTSPLY underperformed the industry. A lowered guidance is discouraging. The company's higher capital expenditure on product development and tough competition are expected to exert pressure on margins. Unfavorable foreign exchange rate and integration risks are major headwinds for the near term. However, DENTSPLY exited the first quarter on a solid note. Robust performance by the flagship dental implants, CAD/CAM systems, imaging systems, treatment centers and orthodontic product platforms hold considerable promise. Emerging markets like Asia-Pacific & the Middle East offer healthy growth opportunities, as they remain vastly untapped with low dental products penetration. The company’s agreements with MedTech bigwig Patterson Companies in Canada are likely to drive sales. DENTSPLY recently witnessed a rebound in sales in Asia, particularly Japan, and strong growth in Russia." (5/11/2018)
  • 2. Jefferies Group LLC analysts commented, "Dynavax provided Phase 1b/2 updates on TLR9 agonist, SD-101 in combination with Keytruda, for head and neck squamous cell carcinoma (HNSCC) and metastatic melanoma at AACR." (4/16/2018)
  • 3. Barrington Research analysts commented, "We are currently modeling adjusted EPS of $2.70 and this is unchanged versus our previous modeling. We suspect that the company will be able to overcome whatever modest dilution comes with this deal over the balance of 2018. That said, we have made some modest adjustments to our quarterly modeling and have attached a model, which is a bit more back-end loaded than previously. We are doing this in part to account for any additional costs associated with the efforts to put this transaction together as well as general conservatism associated with prior disclosures by management relative to the company’s ongoing efforts to work down its inventory levels with certain key distribution channels." (3/27/2018)

Who are some of Dentsply Sirona's key competitors?

Some companies that are related to Dentsply Sirona include Straumann (SAUHF), Sartorius (SARTF), Nobel Biocare (NBHGF), Biomerica (BMRA), Biolase (BIOL) and Remedent (REMI).

Who are Dentsply Sirona's key executives?

Dentsply Sirona's management team includes the folowing people:
  • Mr. Nicholas William Alexos, Exec. VP & CFO (Age 54)
  • Mr. Keith John Ebling, EVP, Gen. Counsel & Sec. (Age 49)
  • Ms. Maureen J. MacInnis, Sr. VP, Chief HR Officer & Communications (Age 57)
  • Mr. Robert J. Size, Interim Pres & COO (Age 59)
  • Mr. Donald M. Casey Jr., CEO & Director (Age 58)

Has Dentsply Sirona been receiving favorable news coverage?

News coverage about XRAY stock has been trending somewhat positive on Sunday, Accern reports. The research firm identifies positive and negative news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Dentsply Sirona earned a media sentiment score of 0.07 on Accern's scale. They also gave news stories about the medical instruments supplier an impact score of 47.24 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near term.

Who are Dentsply Sirona's major shareholders?

Dentsply Sirona's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (6.28%), GENERATION INVESTMENT MANAGEMENT LLP (5.20%), Veritas Asset Management LLP (3.70%), Principal Financial Group Inc. (3.02%), Massachusetts Financial Services Co. MA (2.34%) and Atlanta Capital Management Co. L L C (2.09%). Company insiders that own Dentsply Sirona stock include Arthur D Kowaloff, Bret W Wise, Christopher T Clark, Donald M Jr Casey, Eric Brandt, Francis J Lunger, James G Mosch, Mark Thierer, Maureen J Macinnis, Michael J Coleman, Nicholas W Alexos, Rainer Berthan and Ulrich Michel. View Institutional Ownership Trends for Dentsply Sirona.

Which major investors are selling Dentsply Sirona stock?

XRAY stock was sold by a variety of institutional investors in the last quarter, including Select Equity Group L.P., JPMorgan Chase & Co., Amundi Pioneer Asset Management Inc., Atlantic Trust Group LLC, Frontier Capital Management Co. LLC, Neuberger Berman Group LLC, Sei Investments Co. and Independent Franchise Partners LLP. Company insiders that have sold Dentsply Sirona company stock in the last year include Eric Brandt, Francis J Lunger and Michael J Coleman. View Insider Buying and Selling for Dentsply Sirona.

Which major investors are buying Dentsply Sirona stock?

XRAY stock was purchased by a variety of institutional investors in the last quarter, including Veritas Asset Management LLP, SG Americas Securities LLC, Champlain Investment Partners LLC, Thompson Siegel & Walmsley LLC, Polar Asset Management Partners Inc., Honeywell International Inc., Citigroup Inc. and Prudential Financial Inc.. Company insiders that have bought Dentsply Sirona stock in the last two years include Donald M Jr Casey, Mark Thierer and Nicholas W Alexos. View Insider Buying and Selling for Dentsply Sirona.

How do I buy shares of Dentsply Sirona?

Shares of XRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Dentsply Sirona's stock price today?

One share of XRAY stock can currently be purchased for approximately $46.57.

How big of a company is Dentsply Sirona?

Dentsply Sirona has a market capitalization of $10.59 billion and generates $3.99 billion in revenue each year. The medical instruments supplier earns $-1,550,000,000.00 in net income (profit) each year or $2.66 on an earnings per share basis. Dentsply Sirona employs 16,100 workers across the globe.

How can I contact Dentsply Sirona?

Dentsply Sirona's mailing address is 221 WEST PHILADELPHIA STREET, YORK PA, 17401. The medical instruments supplier can be reached via phone at 717-845-7511 or via email at [email protected]


MarketBeat Community Rating for Dentsply Sirona (XRAY)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  260 (Vote Outperform)
Underperform Votes:  257 (Vote Underperform)
Total Votes:  517
MarketBeat's community ratings are surveys of what our community members think about Dentsply Sirona and other stocks. Vote "Outperform" if you believe XRAY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe XRAY will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Dentsply Sirona (NASDAQ:XRAY) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
13 Wall Street analysts have issued ratings and price targets for Dentsply Sirona in the last 12 months. Their average twelve-month price target is $62.6667, suggesting that the stock has a possible upside of 34.56%. The high price target for XRAY is $75.00 and the low price target for XRAY is $52.00. There are currently 4 hold ratings and 9 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.692.572.542.64
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $62.6667$67.00$68.9167$67.30
Price Target Upside: 34.56% upside33.49% upside10.00% upside1.03% downside

Dentsply Sirona (NASDAQ:XRAY) Consensus Price Target History

Price Target History for Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona (NASDAQ:XRAY) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/16/2018Deutsche BankLower Price TargetBuy$55.00LowView Rating Details
5/8/2018Robert W. BairdLower Price TargetOutperform ➝ Outperform$71.00HighView Rating Details
5/8/2018Barrington ResearchLower Price TargetOutperform ➝ Outperform$70.00 ➝ $54.00HighView Rating Details
5/8/2018BarclaysReiterated RatingHold$55.00HighView Rating Details
5/8/2018Stifel NicolausReiterated RatingBuy ➝ Buy$67.00 ➝ $57.00HighView Rating Details
5/8/2018HC WainwrightLower Price TargetNeutral ➝ Neutral$63.00 ➝ $52.00HighView Rating Details
4/16/2018Jefferies GroupReiterated RatingBuyLowView Rating Details
4/5/2018Cleveland ResearchReiterated RatingHoldLowView Rating Details
3/5/2018JPMorgan Chase & Co.Lower Price TargetOverweight ➝ Overweight$75.00 ➝ $70.00LowView Rating Details
3/2/2018Credit Suisse GroupLower Price TargetOutperform ➝ Outperform$73.00 ➝ $69.00HighView Rating Details
11/28/2017StephensInitiated CoverageOverweight$75.00LowView Rating Details
10/6/2017Morgan StanleyReiterated RatingOverweight$67.00 ➝ $69.00N/AView Rating Details
8/10/2017UBSReiterated RatingNeutral$62.00 ➝ $59.00LowView Rating Details
5/23/2017Goldman Sachs GroupDowngradeNeutral ➝ Sell$60.00 ➝ $55.00MediumView Rating Details
9/12/2016Bank of AmericaInitiated CoverageBuy$70.00N/AView Rating Details
6/27/2016Piper Jaffray CompaniesReiterated RatingBuyN/AView Rating Details
(Data available from 5/27/2016 forward)

Earnings

Dentsply Sirona (NASDAQ:XRAY) Earnings History and Estimates Chart

Earnings by Quarter for Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona (NASDAQ:XRAY) Earnings Estimates

2018 EPS Consensus Estimate: $2.57
2019 EPS Consensus Estimate: $2.84
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20184$0.42$0.43$0.43
Q2 20184$0.58$0.62$0.61
Q3 20184$0.70$0.72$0.71
Q4 20184$0.81$0.83$0.82
Q1 20193$0.49$0.63$0.56
Q2 20193$0.67$0.76$0.71
Q3 20193$0.72$0.78$0.75
Q4 20193$0.79$0.87$0.82

Dentsply Sirona (NASDAQ XRAY) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/7/2018$0.60N/AView Earnings Details
5/6/2018Q1 2018$0.42$0.45$942.20 million$956.10 millionViewN/AView Earnings Details
3/1/2018Q4 2017$0.81$0.82$1.0607 billion$1.0910 billionViewListenView Earnings Details
11/3/2017Q3 2017$0.66$0.70$978.99 million$1.0092 billionViewN/AView Earnings Details
8/9/2017Q2 2017$0.65$0.65$1.0032 billion$992.70 millionViewListenView Earnings Details
5/9/2017Q1 17$0.50$0.49$916.55 million$900.50 millionViewListenView Earnings Details
2/17/2017Q4 2016$0.65$0.67$1.0192 billion$996.50 millionViewListenView Earnings Details
11/4/2016Q316$0.63$0.66$967.68 million$954.20 millionViewListenView Earnings Details
8/5/2016Q216$0.70$0.76$1.03 billion$1.02 billionViewListenView Earnings Details
5/6/2016Q1$0.63$0.69$741.80 million$772.60 millionViewN/AView Earnings Details
2/12/2016Q415$0.65$0.65$687.35 million$671.10 millionViewListenView Earnings Details
10/28/2015Q3$0.63$0.66$667.00 million$648.90 millionViewListenView Earnings Details
7/30/2015Q215$0.68$0.73$715.49 million$698.00 millionViewListenView Earnings Details
5/6/2015Q115$0.57$0.59$690.16 million$656.30 millionViewListenView Earnings Details
2/18/2015Q414$0.61$0.60$751.04 million$719.00 millionViewListenView Earnings Details
10/29/2014Q314$0.60$0.62$725.83 million$708.00 millionViewListenView Earnings Details
7/31/2014Q2$0.68$0.69$782.86 million$765.20 millionViewListenView Earnings Details
5/6/2014Q1$0.56$0.59$747.27 million$730.10 millionViewListenView Earnings Details
2/18/2014Q4$0.61$0.61$767.89 million$753.70 millionViewListenView Earnings Details
10/29/2013Q313$0.56$0.57$716.13 million$704.00 millionViewListenView Earnings Details
8/1/2013Q2 2013$0.65$0.66$782.73 million$761.00 millionViewListenView Earnings Details
5/9/2013Q1 2013$0.56$0.52$732.87 million$732.10 millionViewListenView Earnings Details
2/20/2013Q4 2012$0.56$0.56$748.56 million$753.30 millionViewListenView Earnings Details
10/25/2012$0.50$0.51ViewN/AView Earnings Details
7/31/2012$0.57$0.62ViewN/AView Earnings Details
5/1/2012$0.52$0.52ViewN/AView Earnings Details
2/16/2012$0.52$0.51ViewN/AView Earnings Details
10/27/2011$0.43$0.46ViewN/AView Earnings Details
7/28/2011$0.51$0.55ViewN/AView Earnings Details
4/28/2011$0.48$0.49ViewN/AView Earnings Details
2/9/2011$0.50$0.51ViewN/AView Earnings Details
10/28/2010Q3 2010$0.45$0.45ViewN/AView Earnings Details
7/29/2010Q2 2010$0.51$0.50ViewN/AView Earnings Details
4/29/2010Q1 2010$0.45$0.44ViewN/AView Earnings Details
2/10/2010Q4 2009$0.48$0.48ViewN/AView Earnings Details
10/28/2009Q3 2009$0.44$0.44ViewN/AView Earnings Details
7/29/2009Q2 2009$0.48$0.49ViewN/AView Earnings Details
4/30/2009Q1 2009$0.43$0.43ViewN/AView Earnings Details
2/4/2009Q4 2008$0.46$0.45ViewN/AView Earnings Details
10/28/2008Q3 2008$0.44$0.46ViewN/AView Earnings Details
7/29/2008Q2 2008$0.49$0.53ViewN/AView Earnings Details
4/30/2008Q1 2008$0.43$0.45ViewN/AView Earnings Details
2/5/2008Q4 2007$0.44$0.46ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Dentsply Sirona (NASDAQ:XRAY) Dividend Information

Dentsply Sirona pays an annual dividend of $0.35 per share, with a dividend yield of 0.75%. XRAY's next quarterly dividend payment will be made on Friday, July 13. Dentsply Sirona pays out 13.16% of its earnings out as a dividend.
Next Dividend:7/13/2018
Annual Dividend:$0.35
Dividend Yield:0.75%
Payout Ratio(s):13.16% (Trailing 12 Months of Earnings)
13.51% (Based on This Year's Estimates)
12.20% (Based on Next Year's Estimates)
3.11% (Based on Cash Flow)
Dividend Payments by Quarter for Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona (NASDAQ:XRAY) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/25/2018quarterly$0.08750.71%6/28/20186/29/20187/13/2018
2/14/2018quarterly$0.08750.7%3/28/20183/29/20184/13/2018
12/12/2017quarterly$0.08750.53%12/28/201712/29/20171/12/2018
6/28/2017quarterly$0.08750.54%9/28/20179/29/201710/13/2017
6/22/2017quarterly$0.08750.55%6/28/20176/30/20177/14/2017
2/17/2017quarterly$0.08750.56%3/29/20173/31/20174/13/2017
12/15/2016quarterly$0.07750.52%12/28/201612/30/20161/13/2017
9/22/2016$0.07759/28/20169/30/201610/14/2016
4/11/2016$0.07806/22/20166/24/20167/8/2016
3/3/2016$0.07803/22/20163/25/20164/8/2016
10/1/2015$0.072012/22/201512/25/20151/8/2016
7/29/2015quarterly$0.07259/23/20159/25/201510/9/2015
5/20/2015quarterly$0.07250.55%6/24/20156/26/20157/10/2015
2/24/2015quarterly$0.07250.54%3/25/20153/27/20154/10/2015
9/25/2014quarterly$0.06630.58%12/23/201412/26/20141/9/2015
8/1/2014quarterly$0.06630.57%9/24/20149/26/201410/10/2014
5/22/2014quarterly$0.06630.57%6/25/20146/27/20147/11/2014
2/18/2014quarterly$0.06630.59%3/26/20143/28/20144/11/2014
9/27/2013quarterly$0.06250.58%12/24/201312/27/20131/10/2014
8/1/2013quarterly$0.06250.58%9/25/20139/27/201310/11/2013
5/23/2013quarterly$0.06250.6%6/26/20136/28/20137/12/2013
2/27/2013quarterly$0.06250.61%3/26/20133/29/20134/12/2013
(Data available from 1/1/2013 forward)

Insider Trades

Dentsply Sirona (NASDAQ XRAY) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.93%
Institutional Ownership Percentage: 93.59%
Insider Trading History for Dentsply Sirona (NASDAQ:XRAY)
Institutional Ownership by Quarter for Dentsply Sirona (NASDAQ:XRAY)

Dentsply Sirona (NASDAQ XRAY) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/10/2018Michael J ColemanDirectorSell414$46.66$19,317.2420,650View SEC Filing  
5/9/2018Donald M Jr. CaseyCEOBuy22,500$44.52$1,001,700.0092,408View SEC Filing  
5/9/2018Nicholas W AlexosCFOBuy50,000$44.71$2,235,500.0025,411View SEC Filing  
1/8/2018Eric BrandtDirectorSell6,409$68.04$436,068.3612,073View SEC Filing  
11/13/2017Francis J LungerDirectorSell8,900$65.90$586,510.00View SEC Filing  
11/13/2017Mark ThiererInsiderBuy77,000$66.04$5,085,080.00View SEC Filing  
11/13/2017Nicholas W AlexosCFOBuy50,000$65.85$3,292,500.00View SEC Filing  
4/24/2017James G MoschCEOSell50,600$63.49$3,212,594.00105,083View SEC Filing  
4/7/2017Christopher T ClarkCEOSell89,700$62.67$5,621,499.00112,067View SEC Filing  
3/9/2017Ulrich MichelInsiderSell24,000$62.84$1,508,160.0094,067View SEC Filing  
3/2/2017Eric BrandtDirectorSell2,941$64.35$189,253.354,722View SEC Filing  
3/1/2017Bret W WiseInsiderSell146,900$64.17$9,426,573.00142,121View SEC Filing  
2/17/2017Arthur D KowaloffDirectorSell27,213$62.00$1,687,206.0055,692View SEC Filing  
2/17/2017Christopher T ClarkCEOSell64,500$60.70$3,915,150.0055,916View SEC Filing  
11/17/2016James G MoschCEOSell30,400$60.93$1,852,272.0075,283View SEC Filing  
9/6/2016Rainer BerthanVPSell5,000$61.12$305,600.0034,370View SEC Filing  
8/25/2016Maureen J MacinnisSVPSell45,100$60.55$2,730,805.0036,730View SEC Filing  
8/23/2016Maureen J MacinnisSVPSell17,650$60.61$1,069,766.5019,630View SEC Filing  
6/2/2016Rainer BerthanVPSell6,464$62.56$404,387.8439,341View SEC Filing  
5/26/2016Michael C AlfanoDirectorSell3,000$61.58$184,740.008,758View SEC Filing  
5/16/2016Harry M Jansen Kraemer JrDirectorSell27,213$62.17$1,691,832.2158,262View SEC Filing  
3/29/2016Arthur D KowaloffDirectorSell13,006$62.00$806,372.0042,785View SEC Filing  
11/18/2015Deborah RasinVPSell4,500$60.56$272,520.004,429View SEC Filing  
11/4/2015Michael C AlfanoDirectorSell2,500$62.15$155,375.008,737View SEC Filing  
11/3/2015Deborah RasinVPSell14,000$61.70$863,800.008,929View SEC Filing  
3/30/2015Christopher T ClarkInsiderSell85,566$51.18$4,379,267.88View SEC Filing  
2/20/2015Deborah RasinVPSell11,000$52.47$577,170.00View SEC Filing  
2/20/2015Michael J ColemanDirectorSell18,000$52.47$944,460.00View SEC Filing  
1/9/2015Robert J SizeVPSell9,200$52.97$487,324.00View SEC Filing  
12/8/2014Leslie A JonesDirectorSell18,000$55.45$998,100.00View SEC Filing  
12/4/2014Albert SterkenburgVPSell23,200$55.62$1,290,384.00View SEC Filing  
11/7/2014Michael C AlfanoDirectorSell20,000$51.23$1,024,600.00View SEC Filing  
11/5/2014James G MoschVPSell55,042$51.25$2,820,902.50View SEC Filing  
11/4/2014Francis J LungerDirectorSell9,160$50.90$466,244.00View SEC Filing  
10/31/2014Albert SterkenburgVPSell2,000$50.51$101,020.00View SEC Filing  
10/31/2014John C Miles IIDirectorSell20,000$50.65$1,013,000.00View SEC Filing  
8/25/2014Leslie A JonesDirectorSell2,000$48.30$96,600.00View SEC Filing  
7/3/2014Christopher T ClarkInsiderSell27,521$47.74$1,313,852.54View SEC Filing  
5/30/2014Michael C AlfanoDirectorSell2,764$47.25$130,599.00View SEC Filing  
5/19/2014Leslie JonesDirectorSell2,000$46.49$92,980.0095,892View SEC Filing  
5/12/2014Robert SizeVPSell5,049$46.29$233,718.2111,588View SEC Filing  
12/11/2013Bret WiseChairmanSell90,000$48.50$4,365,000.0021,724View SEC Filing  
12/9/2013Francis LungerDirectorSell18,000$47.66$857,880.004,322View SEC Filing  
12/6/2013Bret WiseChairmanSell24,323$47.66$1,159,234.1830,294View SEC Filing  
12/2/2013Bret WiseChairmanSell66,761$47.53$3,173,150.3330,294View SEC Filing  
12/2/2013William HechtDirectorSell18,000$47.49$854,820.0018,000View SEC Filing  
11/8/2013Leslie JonesDirectorSell2,000$47.68$95,360.0097,892View SEC Filing  
10/21/2013Robert J SizeVPSell14,262$46.00$656,052.00View SEC Filing  
9/11/2013Robert SizeVPSell8,200$45.00$369,000.0011,501View SEC Filing  
9/10/2013James G MoschVPSell41,836$43.95$1,838,692.20View SEC Filing  
7/31/2013Christopher T ClarkInsiderSell20,918$43.00$899,474.00View SEC Filing  
7/31/2013Eric BrandtDirectorSell18,000$43.00$774,000.00View SEC Filing  
7/9/2013Christopher T ClarkInsiderSell20,918$42.00$878,556.00View SEC Filing  
6/3/2013Leslie A JonesDirectorSell2,840$41.76$118,598.40View SEC Filing  
3/12/2013Paula H CholmondeleyDirectorSell9,000$42.70$384,300.00View SEC Filing  
12/21/2012Bret W WiseChairmanSell4,349$40.50$176,134.50View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Dentsply Sirona (NASDAQ XRAY) News Headlines

Source:
DateHeadline
Heres Why You Should Sell DENTSPLY SIRONA (XRAY) Stock NowHere's Why You Should Sell DENTSPLY SIRONA (XRAY) Stock Now
www.zacks.com - May 18 at 8:03 AM
Dentsply Sirona (XRAY) Upgraded at ValuEngineDentsply Sirona (XRAY) Upgraded at ValuEngine
www.americanbankingnews.com - May 16 at 4:51 PM
Dentsply Sirona (XRAY) Given New $55.00 Price Target at Deutsche BankDentsply Sirona (XRAY) Given New $55.00 Price Target at Deutsche Bank
www.americanbankingnews.com - May 16 at 1:49 PM
Dentsply Sirona (XRAY) Receives Average Rating of "Hold" from AnalystsDentsply Sirona (XRAY) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - May 15 at 3:44 AM
 Analysts Expect Dentsply Sirona (XRAY) Will Post Quarterly Sales of $1.03 Billion Analysts Expect Dentsply Sirona (XRAY) Will Post Quarterly Sales of $1.03 Billion
www.americanbankingnews.com - May 15 at 2:48 AM
 Brokerages Expect Dentsply Sirona (XRAY) Will Announce Earnings of $0.60 Per Share Brokerages Expect Dentsply Sirona (XRAY) Will Announce Earnings of $0.60 Per Share
www.americanbankingnews.com - May 13 at 1:24 PM
Zacks Investment Research Downgrades Dentsply Sirona (XRAY) to SellZacks Investment Research Downgrades Dentsply Sirona (XRAY) to Sell
www.americanbankingnews.com - May 11 at 6:31 PM
Insider Selling: Dentsply Sirona (XRAY) Director Sells 414 Shares of StockInsider Selling: Dentsply Sirona (XRAY) Director Sells 414 Shares of Stock
www.americanbankingnews.com - May 11 at 4:46 PM
Dentsply Sirona (XRAY) to Post Q2 2018 Earnings of $0.58 Per Share, Barrington Research ForecastsDentsply Sirona (XRAY) to Post Q2 2018 Earnings of $0.58 Per Share, Barrington Research Forecasts
www.americanbankingnews.com - May 11 at 8:15 AM
Barrington Research Analysts Decrease Earnings Estimates for Dentsply Sirona (XRAY)Barrington Research Analysts Decrease Earnings Estimates for Dentsply Sirona (XRAY)
www.americanbankingnews.com - May 10 at 7:58 AM
Q3 2018 Earnings Forecast for Dentsply Sirona (XRAY) Issued By William BlairQ3 2018 Earnings Forecast for Dentsply Sirona (XRAY) Issued By William Blair
www.americanbankingnews.com - May 10 at 7:16 AM
Research Analysts Offer Predictions for Dentsply Sironas Q2 2018 Earnings (XRAY)Research Analysts Offer Predictions for Dentsply Sirona's Q2 2018 Earnings (XRAY)
www.americanbankingnews.com - May 10 at 6:14 AM
Insider Buying: Dentsply Sirona (XRAY) CEO Buys 22,500 Shares of StockInsider Buying: Dentsply Sirona (XRAY) CEO Buys 22,500 Shares of Stock
www.americanbankingnews.com - May 9 at 7:37 PM
Dentsply Sirona (XRAY) CFO Nicholas W. Alexos Purchases 50,000 SharesDentsply Sirona (XRAY) CFO Nicholas W. Alexos Purchases 50,000 Shares
www.americanbankingnews.com - May 9 at 7:17 PM
Edited Transcript of XRAY earnings conference call or presentation 7-May-18 12:30pm GMTEdited Transcript of XRAY earnings conference call or presentation 7-May-18 12:30pm GMT
finance.yahoo.com - May 9 at 5:54 PM
Q3 2018 Earnings Estimate for Dentsply Sirona Issued By Jefferies Group (XRAY)Q3 2018 Earnings Estimate for Dentsply Sirona Issued By Jefferies Group (XRAY)
www.americanbankingnews.com - May 9 at 8:39 AM
Q2 2018 EPS Estimates for Dentsply Sirona (XRAY) Decreased by AnalystQ2 2018 EPS Estimates for Dentsply Sirona (XRAY) Decreased by Analyst
www.americanbankingnews.com - May 9 at 8:23 AM
Q2 2018 EPS Estimates for Dentsply Sirona Decreased by William Blair (XRAY)Q2 2018 EPS Estimates for Dentsply Sirona Decreased by William Blair (XRAY)
www.americanbankingnews.com - May 9 at 8:23 AM
ValuEngine Lowers Dentsply Sirona (XRAY) to Strong SellValuEngine Lowers Dentsply Sirona (XRAY) to Strong Sell
www.americanbankingnews.com - May 8 at 11:26 PM
DENTSPLY SIRONA is Now Oversold (XRAY)DENTSPLY SIRONA is Now Oversold (XRAY)
www.nasdaq.com - May 8 at 5:57 PM
Dentsply Sirona (XRAY) Stock Rating Reaffirmed by BarclaysDentsply Sirona (XRAY) Stock Rating Reaffirmed by Barclays
www.americanbankingnews.com - May 8 at 3:45 PM
Dentsply Sirona (XRAY) Stock Rating Reaffirmed by Stifel NicolausDentsply Sirona (XRAY) Stock Rating Reaffirmed by Stifel Nicolaus
www.americanbankingnews.com - May 8 at 3:32 PM
Robert W. Baird Lowers Dentsply Sirona (XRAY) Price Target to $56.00Robert W. Baird Lowers Dentsply Sirona (XRAY) Price Target to $56.00
www.americanbankingnews.com - May 8 at 3:29 PM
Dentsply Sirona (XRAY) Price Target Cut to $52.00 by Analysts at HC WainwrightDentsply Sirona (XRAY) Price Target Cut to $52.00 by Analysts at HC Wainwright
www.americanbankingnews.com - May 8 at 1:23 PM
Dentsply Sirona (XRAY) Posts Quarterly  Earnings ResultsDentsply Sirona (XRAY) Posts Quarterly Earnings Results
www.americanbankingnews.com - May 8 at 11:32 AM
Dentsply Sirona (XRAY) Price Target Cut to $54.00 by Analysts at Barrington ResearchDentsply Sirona (XRAY) Price Target Cut to $54.00 by Analysts at Barrington Research
www.americanbankingnews.com - May 8 at 10:22 AM
Dentsply Sirona Q1 Results Top Estimates; But Cuts 2018 OutlookDentsply Sirona Q1 Results Top Estimates; But Cuts 2018 Outlook
www.nasdaq.com - May 7 at 5:50 PM
Dentsply Sirona (XRAY) Releases FY18 Earnings GuidanceDentsply Sirona (XRAY) Releases FY18 Earnings Guidance
www.americanbankingnews.com - May 7 at 9:16 AM
Dentsply: 1Q Earnings SnapshotDentsply: 1Q Earnings Snapshot
finance.yahoo.com - May 7 at 8:06 AM
Will Dentsply Sirona Recover from Its Recent Stock Price Lows?Will Dentsply Sirona Recover from Its Recent Stock Price Lows?
finance.yahoo.com - May 7 at 8:06 AM
Should You Buy DENTSPLY SIRONA Inc (NASDAQ:XRAY)?Should You Buy DENTSPLY SIRONA Inc (NASDAQ:XRAY)?
finance.yahoo.com - May 6 at 7:58 PM
Head to Head Analysis: Sartorius (SARTF) & Dentsply Sirona (XRAY)Head to Head Analysis: Sartorius (SARTF) & Dentsply Sirona (XRAY)
www.americanbankingnews.com - May 6 at 5:53 AM
Whats in Store for DENTSPLY (XRAY) This Earnings Season?What's in Store for DENTSPLY (XRAY) This Earnings Season?
www.msn.com - May 3 at 8:02 AM
What's in Store for DENTSPLY (XRAY) This Earnings Season?What's in Store for DENTSPLY (XRAY) This Earnings Season?
finance.yahoo.com - May 2 at 5:49 PM
Head to Head Comparison: Sartorius (SARTF) vs. Dentsply Sirona (XRAY)Head to Head Comparison: Sartorius (SARTF) vs. Dentsply Sirona (XRAY)
www.americanbankingnews.com - May 2 at 5:44 PM
Dentsply Sirona (XRAY) Downgraded by ValuEngine to SellDentsply Sirona (XRAY) Downgraded by ValuEngine to Sell
www.americanbankingnews.com - May 2 at 1:13 PM
Wall Street Analysts Raise Target Prices on ALGN after 1Q18 EarningsWall Street Analysts Raise Target Prices on ALGN after 1Q18 Earnings
finance.yahoo.com - April 30 at 8:02 AM
Dentsply Sirona (XRAY) Scheduled to Post Quarterly Earnings on SundayDentsply Sirona (XRAY) Scheduled to Post Quarterly Earnings on Sunday
www.americanbankingnews.com - April 29 at 5:32 AM
Financial Contrast: Dentsply Sirona (XRAY) vs. Biolase (BIOL)Financial Contrast: Dentsply Sirona (XRAY) vs. Biolase (BIOL)
www.americanbankingnews.com - April 28 at 3:32 PM
Zacks: Analysts Expect Dentsply Sirona (XRAY) Will Announce Quarterly Sales of $944.67 MillionZacks: Analysts Expect Dentsply Sirona (XRAY) Will Announce Quarterly Sales of $944.67 Million
www.americanbankingnews.com - April 28 at 4:58 AM
Head to Head Contrast: Dentsply Sirona (XRAY) and Biolase (BIOL)Head to Head Contrast: Dentsply Sirona (XRAY) and Biolase (BIOL)
www.americanbankingnews.com - April 26 at 9:40 PM
Global Dental Market Size, Trends & Forecasts 2018-2022 with Dentsply Sirona, Danaher, 3M Company & Planmeca Group Playing Key RolesGlobal Dental Market Size, Trends & Forecasts 2018-2022 with Dentsply Sirona, Danaher, 3M Company & Planmeca Group Playing Key Roles
www.prnewswire.com - April 26 at 6:10 PM
Al Gore’s Firm Is Buying These Two StocksAl Gore’s Firm Is Buying These Two Stocks
www.barrons.com - April 26 at 5:27 PM
Al Gores Firm Is Buying These Two StocksAl Gore's Firm Is Buying These Two Stocks
finance.yahoo.com - April 26 at 5:27 PM
 Analysts Expect Dentsply Sirona (XRAY) Will Announce Earnings of $0.43 Per Share Analysts Expect Dentsply Sirona (XRAY) Will Announce Earnings of $0.43 Per Share
www.americanbankingnews.com - April 26 at 3:16 AM
Dentsply Sirona (XRAY) Short Interest UpdateDentsply Sirona (XRAY) Short Interest Update
www.americanbankingnews.com - April 26 at 2:22 AM
Dentsply Sirona (XRAY) Declares Quarterly Dividend of $0.09Dentsply Sirona (XRAY) Declares Quarterly Dividend of $0.09
www.americanbankingnews.com - April 25 at 6:52 PM
Dentsply Sirona to Host First Quarter 2018 Conference Call on May 7thDentsply Sirona to Host First Quarter 2018 Conference Call on May 7th
finance.yahoo.com - April 25 at 5:41 PM
Dentsply Sirona Target of Unusually Large Options Trading (XRAY)Dentsply Sirona Target of Unusually Large Options Trading (XRAY)
www.americanbankingnews.com - April 24 at 6:43 AM
Dentsply Sirona (XRAY) versus Straumann (SAUHF) Financial ReviewDentsply Sirona (XRAY) versus Straumann (SAUHF) Financial Review
www.americanbankingnews.com - April 23 at 9:14 AM

SEC Filings

Dentsply Sirona (NASDAQ:XRAY) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Dentsply Sirona (NASDAQ:XRAY) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Dentsply Sirona (NASDAQ XRAY) Stock Chart for Sunday, May, 27, 2018

Loading chart…

This page was last updated on 5/27/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.